Shared molecular and functional frameworks among five complex human disorders: A comparative study on interactomes linked to susceptibility genes

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Menon, Ramesh ^a,b   Farina, Cinthia ^a,b  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; HLA DQA1 ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 3; PLATELET DERIVED GROWTH FACTOR; PROTEIN TYROSINE KINASE A; PROTEIN TYROSINE PHOSPHATASE SHP 2; SOMATOMEDIN C; SPROUTY PROTEIN; TREFOIL PEPTIDE; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1;

ALZHEIMER DISEASE; ARTICLE; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNE RESPONSE; INSULIN DEPENDENT DIABETES MELLITUS; MOLECULAR PHYLOGENY; MULTIPLE SCLEROSIS; PARKINSON DISEASE; PATHOGENESIS; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY; AUTOIMMUNE DISEASE; COMPARATIVE STUDY; DEGENERATIVE DISEASE; GENETICS;

AUTOIMMUNE DISEASES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEURODEGENERATIVE DISEASES;

EID: 79955453474     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018660     Document Type: Article

References (40)

1. Barrenas F, Chavali S, Holme P, Mobini R, Benson M, (2009) Network properties of complex human disease genes identified through genome-wide association studies. PLoS One 4: e8090.
2. Feldman I, Rzhetsky A, Vitkup D, (2008) Network properties of genes harboring inherited disease mutations. Proc Natl Acad Sci U S A 105: 4323-4328.
3. Trapp BD, Nave KA, (2008) Multiple sclerosis: An immune or neurodegenerative disorder? Annu Rev Neurosci 31: 247-269.
4. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, et al. (2009) Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A 106: 9362-9367.
5. Seldin MF, Amos CI, (2009) Shared susceptibility variations in autoimmune diseases: A brief perspective on common issues. Genes Immun 10: 1-4.
6. Zenewicz LA, Abraham C, Flavell RA, Cho JH, (2010) Unraveling the genetics of autoimmunity. Cell 140: 791-797.
7. Zoledziewska M, Costa G, Pitzalis M, Cocco E, Melis C, et al. (2009) Variation within the CLEC16A gene shows consistent disease association with both multiple sclerosis and type 1 diabetes in sardinia. Genes Immun 10: 15-17.
8. Hafler DA, Compston A, Sawcer S, Lander ES, et al. International Multiple Sclerosis Genetics Consortium (2007) Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 357: 851-862.
9. Lowe CE, Cooper JD, Brusko T, Walker NM, Smyth DJ, et al. (2007) Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes. Nat Genet 39: 1074-1082.
10. Baranzini SE, (2009) The genetics of autoimmune diseases: A networked perspective. Curr Opin Immunol 21: 596-605.
11. Moskvina V, Craddock N, Holmans P, Nikolov I, Pahwa JS, et al. (2009) Gene-wide analyses of genome-wide association data sets: Evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk. Mol Psychiatry 14: 252-260.
12. Huang R, Wallqvist A, Covell DG, (2006) Comprehensive analysis of pathway or functionally related gene expression in the national cancer institute's anticancer screen. Genomics 87: 315-328.
13. Zhong H, Yang X, Kaplan LM, Molony C, Schadt EE, (2010) Integrating pathway analysis and genetics of gene expression for genome-wide association studies. Am J Hum Genet 86: 581-591.
14. Li Y, Agarwal P, (2009) A pathway-based view of human diseases and disease relationships. PLoS One 4: e4346.
15. Baranzini SE, Galwey NW, Wang J, Khankhanian P, Lindberg R, et al. (2009) Pathway and network-based analysis of genome-wide association studies in multiple sclerosis. Hum Mol Genet 18: 2078-2090.
16. Town T, Tan J, Flavell RA, Mullan M, (2005) T-cells in alzheimer's disease. Neuromolecular Med 7: 255-264.
17. McGeer PL, Schulzer M, McGeer EG, (1996) Arthritis and anti-inflammatory agents as possible protective factors for alzheimer's disease: A review of 17 epidemiologic studies. Neurology 47: 425-432.
18. Vlad SC, Miller DR, Kowall NW, Felson DT, (2008) Protective effects of NSAIDs on the development of alzheimer disease. Neurology 70: 1672-1677.
19. Zipp F, Aktas O, (2006) The brain as a target of inflammation: Common pathways link inflammatory and neurodegenerative diseases. Trends Neurosci 29: 518-527.
20. Scalabrino G, Galimberti D, Mutti E, Scalabrini D, Veber D, et al. (2010) Loss of epidermal growth factor regulation by cobalamin in multiple sclerosis. Brain Res 1333: 64-71.
21. Nah SS, Won HJ, Ha E, Kang I, Cho HY, et al. (2010) Epidermal growth factor increases prostaglandin E2 production via ERK1/2 MAPK and NF-kappaB pathway in fibroblast like synoviocytes from patients with rheumatoid arthritis. Rheumatol Int 30: 443-449.
22. Refolo LM, Salton SR, Anderson JP, Mehta P, Robakis NK, (1989) Nerve and epidermal growth factors induce the release of the alzheimer amyloid precursor from PC 12 cell cultures. Biochem Biophys Res Commun 164: 664-670.
23. Miettinen PJ, Ustinov J, Ormio P, Gao R, Palgi J, et al. (2006) Downregulation of EGF receptor signaling in pancreatic islets causes diabetes due to impaired postnatal beta-cell growth. Diabetes 55: 3299-3308.
24. Hart AW, Baeza N, Apelqvist A, Edlund H, (2000) Attenuation of FGF signalling in mouse beta-cells leads to diabetes. Nature 408: 864-868.
25. Mashayekhi F, Mirzajani E, Naji M, Azari M, (2010) Expression of insulin-like growth factor-1 and insulin-like growth factor binding proteins in the serum and cerebrospinal fluid of patients with parkinson's disease. J Clin Neurosci 17: 623-627.
26. Freude S, Schilbach K, Schubert M, (2009) The role of IGF-1 receptor and insulin receptor signaling for the pathogenesis of alzheimer's disease: From model organisms to human disease. Curr Alzheimer Res 6: 213-223.
27. Kim B, Backus C, Oh S, Hayes JM, Feldman EL, (2009) Increased tau phosphorylation and cleavage in mouse models of type 1 and type 2 diabetes. Endocrinology 150: 5294-5301.
28. Jolivalt CG, Hurford R, Lee CA, Dumaop W, Rockenstein E, et al. (2010) Type 1 diabetes exaggerates features of alzheimer's disease in APP transgenic mice. Exp Neurol 223: 422-431.
29. Taguchi A, (2009) Vascular factors in diabetes and alzheimer's disease. J Alzheimers Dis 16: 859-864.
30. Sharief MK, Hentges R, Ciardi M, (1991) Intrathecal immune response in patients with the post-polio syndrome. N Engl J Med 325: 749-755.
31. Kollias G, Douni E, Kassiotis G, Kontoyiannis D, (1999) The function of tumour necrosis factor and receptors in models of multi-organ inflammation, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease. Ann Rheum Dis 58 (Suppl 1): I32-9.
32. Taylor PC, (2009) How do the efficacy and safety of abatacept and infliximab compare in the treatment of active RA? Nat Clin Pract Rheumatol 5: 126-127.
33. (1999) TNF neutralization in MS: Results of a randomized, placebo-controlled multicenter study. the lenercept multiple sclerosis study group and the university of british columbia MS/MRI analysis group. Neurology 53: 457-465.
34. Chervonsky AV, (1999) Apoptotic and effector pathways in autoimmunity. Curr Opin Immunol 11: 684-688.
35. Gatzka M, Walsh CM, (2007) Apoptotic signal transduction and T cell tolerance. Autoimmunity 40: 442-452.
36. S Roriz-Filho J, Sa-Roriz TM, Rosset I, Camozzato AL, Santos AC, et al. (2009) (Pre)diabetes, brain aging, and cognition. Biochim Biophys Acta 1792: 432-443.
37. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P, (2006) Risk of dementia in diabetes mellitus: A systematic review. Lancet Neurol 5: 64-74.
38. Craft S, Watson GS, (2004) Insulin and neurodegenerative disease: Shared and specific mechanisms. Lancet Neurol 3: 169-178.
39. Hu Z, Snitkin ES, DeLisi C, (2008) VisANT: An integrative framework for networks in systems biology. Brief Bioinform 9: 317-325.
40. Fisher, A R, (1932) Statistical methods for research workers. Edinburgh Oliver & Boyd.